Serum levels of cartilage oligomeric matrix protein

By Skoumal M.   Kolarz G.   Klingler A.  

Scandinavian Journal of Rheumatology, Vol. 32, Iss. 3, 2003-05 ,pp. : 156-161

Informa Healthcare

Access to resources Recommend Favorite

Can Tocilizumab Decrease Cartilage Oligomeric Matrix Protein Levels and Disease Activity in Patients with Long-Standing Rheumatoid Arthritis?

By  

Current Rheumatology Reviews, Vol. 10, Iss. 2, 2014-09 ,pp. : 131-135

Bentham Science Publishers

Access to resources Recommend Favorite

Antibodies against cyclic citrullinated peptide (CCP) and levels of cartilage oligomeric matrix protein (COMP) in very early arthritis: relation to diagnosis and disease activity

By Söderlin MK   Kastbom A   Kautiainen H   Leirisalo-Repo M   Strandberg G   Skogh T  

Scandinavian Journal of Rheumatology, Vol. 33, Iss. 3, 2004-05 ,pp. : 185-188

Informa Healthcare

Access to resources Recommend Favorite

Cartilage oligomeric matrix protein in serum and synovial fluid of rheumatoid arthritis: potential use as a marker for joint cartilage damage

By Momohara Shigeki   Yamanaka Hisashi   Holledge Masumi Maruo   Mizumura Tamao   Ikari Katsunori   Okada Naoyuki   Kamatani Naoyuki   Tomatsu Taisuke  

Modern Rheumatology, Vol. 14, Iss. 5, 2004-11 ,pp. : 356-360

Springer Publishing Company

Access to resources Recommend Favorite

Serum cartilage oligomeric matrix protein (COMP) levels in knee osteoarthritis in a Brazilian population: clinical and radiological correlation

By Fernandes F. A.   Pucinelli M. L. C.   da Silva N. P.   Feldman D.  

Scandinavian Journal of Rheumatology, Vol. 36, Iss. 3, 2007-01 ,pp. : 211-215

Informa Healthcare

Access to resources Recommend Favorite